SUPERLUMINAL MEDICINES Trademark

Trademark Overview


On Friday, October 6, 2023, a trademark application was filed for SUPERLUMINAL MEDICINES with the United States Patent and Trademark Office. The USPTO has given the SUPERLUMINAL MEDICINES trademark a serial number of 98212701. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, March 3, 2025. This trademark is owned by Superluminal Medicines, Inc.. The SUPERLUMINAL MEDICINES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical agents modulating high value protein targets such as G protein coupled receptors

Development of pharmaceutical preparations and medicines
superluminal medicines

General Information


Serial Number98212701
Word MarkSUPERLUMINAL MEDICINES
Filing DateFriday, October 6, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, March 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2024

Trademark Statements


Goods and ServicesPharmaceutical agents modulating high value protein targets such as G protein coupled receptors
NOT AVAILABLE"MEDICINES"
Goods and ServicesDevelopment of pharmaceutical preparations and medicines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, October 14, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 14, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSuperluminal Medicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Party NameSuperluminal Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events


Event DateEvent Description
Tuesday, October 10, 2023NEW APPLICATION ENTERED
Tuesday, May 28, 2024ASSIGNED TO EXAMINER
Saturday, October 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 4, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 4, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 4, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, June 4, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, June 19, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2024PUBLISHED FOR OPPOSITION
Monday, March 3, 2025SOU EXTENSION 1 FILED
Monday, March 3, 2025SOU EXTENSION 1 GRANTED
Tuesday, March 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 3, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT